Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€512.50
12.12.22
-
12.12.23
-12.07%
06.03.23

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€156.72
09.12.22
-
09.12.23
-11.18%
10.12.23

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€84.27
02.12.22
-
02.12.23
-15.37%
03.12.23

buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€524.60
01.12.22
-
01.12.23
-14.17%
03.03.23

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€82.42
28.11.22
€100.00
28.11.23
1.15%
10.12.22

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€100.60
08.11.22
€150.00
31.01.25
5.77%
05.05.23

Could be worthwhile Investment >10% per year
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€99.82
08.11.22
-
08.11.23
-11.07%
09.11.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€360.60
07.11.22
-
07.11.23
-12.22%
31.01.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€370.05
04.11.22
€610.00
04.11.23
44.17%
05.11.23

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€362.45
03.11.22
-
03.11.23
-12.83%
05.02.23

buy
Anthem Inc.

Start price
Target price
Perf. (%)
€544.20
03.11.22
-
03.11.23
-19.67%
05.02.23

Johnson & Johnson

Start price
Target price
Perf. (%)
€176.04
01.11.22
-
01.11.23
-6.85%
12.11.22

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€758.30
01.11.22
€900.00
01.11.23
-9.34%
05.05.23

Could be very worthwhile Investment >20% year
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€269.40
31.10.22
-
31.10.23
-20.19%
14.05.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€362.80
29.10.22
€400.00
29.10.23
6.95%
05.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€316.75
29.10.22
-
29.11.22
-3.65%
30.11.22

Davita Inc.

Start price
Target price
Perf. (%)
€71.57
29.10.22
€35.00
29.10.23
-2.56%
12.11.22

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€79.55
28.10.22
-
28.11.22
3.51%
29.11.22

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€78.68
28.10.22
-
28.10.23
-7.17%
18.05.23

Risky Investment
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€301.55
28.10.22
-
28.10.23
-10.79%
01.01.23

Risky Investment
buy
Edwards Lifesciences Corp.

Start price
Target price
Perf. (%)
€70.68
28.10.22
-
28.10.23
2.39%
28.10.22

Risky Investment
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
buy
Teleflex Inc.

Start price
Target price
Perf. (%)
€198.00
22.10.22
€210.00
22.10.23
-11.62%
23.10.23

buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€519.40
20.10.22
€530.00
20.10.23
-15.56%
21.10.23

buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€216.45
20.10.22
€230.00
20.11.22
16.61%
21.11.22